Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare ...

Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting ...

Baxter International stock has reached a new 52-week low, touching $16.99, bringing the healthcare equipment company’s market capitalization to $8.76 billion. Despite the decline, InvestingPro ...

Shares of Baxter International Inc. BAX slipped 1.84% to $17.08 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.01% to 6, ...

Baxter International faces deep investor skepticism after disappointing guidance and management's decision to delay its Investor Day. Recent leadership changes and a flattened organizational structure ...

Baxter International BAX recently announced the launch of five new injectable pharmaceutical products in the United States, which, when combined with the previous five launches announced in April 2024 ...

Before market open, Baxter published those quarterly figures. They revealed that total sales rose 5% year over year to $2.84 billion, while net income not according to generally accepted accounting ...

Baxter International beat Wall Street estimates today, and shares surged as the medical equipment company projected healthy growth next year following the completion of a massive restructuring plan.

Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year ...